These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11906253)

  • 21. Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel.
    Sonnemann J; Gekeler V; Ahlbrecht K; Brischwein K; Liu C; Bader P; Müller C; Niethammer D; Beck JF
    Cancer Lett; 2004 Jun; 209(2):177-85. PubMed ID: 15159020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei.
    Wang HY; Chen JX; Sun YX; Deng JZ; Li C; Zhang XZ; Zhuo RX
    J Control Release; 2011 Oct; 155(1):26-33. PubMed ID: 21187118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature.
    Anderson EM; Miller P; Ilsley D; Marshall W; Khvorova A; Stein CA; Benimetskaya L
    Cancer Gene Ther; 2006 Apr; 13(4):406-14. PubMed ID: 16195754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.
    Guensberg P; Wacheck V; Lucas T; Monia B; Pehamberger H; Eichler HG; Jansen B
    Chemotherapy; 2002 Sep; 48(4):189-95. PubMed ID: 12218266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines.
    Hong JH; Lee E; Hong J; Shin YJ; Ahn H
    BJU Int; 2002 Jul; 90(1):113-7. PubMed ID: 12081782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
    Dean NM; McKay R; Condon TP; Bennett CF
    J Biol Chem; 1994 Jun; 269(23):16416-24. PubMed ID: 7911467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
    Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
    Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
    Yang X; Koh CG; Liu S; Pan X; Santhanam R; Yu B; Peng Y; Pang J; Golan S; Talmon Y; Jin Y; Muthusamy N; Byrd JC; Chan KK; Lee LJ; Marcucci G; Lee RJ
    Mol Pharm; 2009; 6(1):221-30. PubMed ID: 19183107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
    Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
    Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.
    van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM
    Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide.
    Simões-Wüst AP; Schürpf T; Hall J; Stahel RA; Zangemeister-Wittke U
    Breast Cancer Res Treat; 2002 Nov; 76(2):157-66. PubMed ID: 12452453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
    Zangemeister-Wittke U; Leech SH; Olie RA; Simões-Wüst AP; Gautschi O; Luedke GH; Natt F; Häner R; Martin P; Hall J; Nalin CM; Stahel RA
    Clin Cancer Res; 2000 Jun; 6(6):2547-55. PubMed ID: 10873111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.
    Rubenstein M; Tsui P; Guinan P
    Med Oncol; 2007; 24(2):189-96. PubMed ID: 17848743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient delivery of the Bcl-2 antisense oligonucleotide G3139 via nucleus-targeted aCD33-NKSN nanoparticles.
    Yan C; Gu J; Zhang Y; Ma K; Lee RJ
    Int J Pharm; 2022 Sep; 625():122074. PubMed ID: 35932928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization.
    Lochmann D; Weyermann J; Georgens C; Prassl R; Zimmer A
    Eur J Pharm Biopharm; 2005 Apr; 59(3):419-29. PubMed ID: 15760722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo electroporetic transfer of bcl-2 antisense oligonucleotide inhibits the development of hepatocellular carcinoma in rats.
    Baba M; Iishi H; Tatsuta M
    Int J Cancer; 2000 Jan; 85(2):260-6. PubMed ID: 10629087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense therapy in oncology: new hope for an old idea?
    Tamm I; Dörken B; Hartmann G
    Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs.
    Kitada S; Miyashita T; Tanaka S; Reed JC
    Antisense Res Dev; 1993; 3(2):157-69. PubMed ID: 8400801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.